What can be learned from otolaryngologists’ experiences in prescribing biologics for patients with chronic rhinosinusitis with nasal polyposis (CRSwNP), including prescribing practices, patient factors guiding prescriber decisions, and physician
Biologics For Chronic Rhinosinusitis: How And When To Use Them For The Best Response
Biologics represent a breakthrough for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). But with high non-response rates and other unresolved issues, researchers are exploring how best to put these therapies to work, panelists said in a session at the Triological Society Combined Sections Meeting.
What Otolaryngologists Need to Know about Biologics and Allergic Rhinitis
Are Biologics Viable Options for Treating Pediatric Illness?
Physician experts at the 2022 Triological Society Combined Sections Meeting discussed biologic therapy options for pediatrics chronic rhinosinusitis with polyps and recurrent respiratory papillomatosis.
Are New Biologics a Game Changer for Treating Nasal Polyposis?
